Remove Biotech Remove Innovation Remove Technical Review
article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

IPO Readiness: What Biotech Startups And Others Need To Know

Crunchbase News

Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.

Biotech 99
article thumbnail

This VC built a lab to make building biotech startups easier

TechCrunch

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. where do you travel to in your mind? The Bay Area?

Biotech 203
article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.

Biotech 178
article thumbnail

14 climate tech investors share their H1 2022 strategies

TechCrunch

Last year, round sizes for climate tech startups quadrupled, with more than 600 investments totaling over $40 billion. What is your climate tech investment thesis in H1 2022? Which technologies are you paying attention to right now? electric scooters, replaceable battery technologies) generate a high volume of e-waste.

article thumbnail

FDA decision to allow over-the-counter hearing loss technology will be a catalyst for innovation

TechCrunch

The hearing loss market has long been dominated by a handful of legacy players with little incentive to innovate due to outdated regulations and social stigma. On Monday, the FDA announced that hearing aids and other hearing technology can now be sold over the counter. But a new ruling from the U.S.

article thumbnail

The 10 Biggest Rounds Of January: Infinite Reality Tops Busy Month

Crunchbase News

Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. The Norwalk, Connecticut-based firm did not disclose investor names, instead saying it came from a private investor whose portfolio focuses on global technology and real estate investments.

Biotech 123